Search

You searched for "quality"

1826 results found

Fife councillors experience street obstacles wearing sight loss simulation-spectacles

27 November 2023 | RNIB, retinopathy, glaucoma, cataract, urban, Navigation, Social Eyes
A cross-party group of Dunfermline Councillors tried to navigate around obstacles and clutter on the streets of Dunfermline on the morning of Friday, November 24th wearing spectacles that mimic different sight loss conditions.
Clinical & Experimental Ophthalmology journal cover image.

PERG as a visual prognosticator in chiasmatic tumours

1 April 2014 | | EYE - General
Pattern electroretinogram (PERG) allows assessment of ganglion cell function and may therefore be used to assess anterior visual pathway dysfunction. This prospective non-randomised study assessed PERG before and after surgical removal of tumours in and around the sellar region compressing...
Journal of Pediatric Ophthalmology & Strabismus cover image.

Questionable ERG use for Vigabatrin screening

5 April 2022 | | EYE - Paediatrics, EYE - Strabismus
The authors aimed to identify the usefulness of electroretinograms (ERGs) as screening for retinal toxicity in patients taking Vigabatrin in a single centre study. This was a retrospective review of full field ERGs and included 170 ERGs of 138 patients...
Neuro-ophthalmology front cover image.

Assaying acetylcholine receptor antibodies in the diagnosis of ocular myasthenia

1 December 2022 | | EYE - Neuro-ophthalmology | Ocular myasthenia, anti-acetyl choline receptor antibody, generalised myasthenia
Myasthenia gravis (MG) is an autoimmune disease that leads to impaired neuromuscular transmission. Solely ocular manifestations of MG (OMG) occur in 15-50% of cases, most frequently in the form of fluctuating ptosis and diplopia. Most cases of OMG convert later...
Ophthalmic Genetics cover picture

Transcriptomic and regulatory gene associations in open angle glaucoma

4 August 2025 | | EYE - Glaucoma
The authors report a study utilising a publicly available whole exome sequencing dataset of 28 patients with primary open angle glaucoma (POAG) and seven healthy control patients, and a transcriptomic dataset from the trabecular meshwork of four POAG patients and...

Celebrating 225 years of seeing ability in parliament

14 November 2024 | charity, patient stories, government, politics, NHS, achievements
This October, the House of Lords provided the venue for charity SeeAbility’s celebration of its 225th-year anniversary, with people it supports, colleagues, volunteers, funders and partners. They were joined by parliamentarians, including the Rt Hon Lord David Blunkett, who sponsored...

Looking on the brightside: Lord David Blunkett

4 December 2025 | | EYE - General
“I can hear people smile” As a young adult in the 1980s and 1990s I gradually became more politically informed with occasional forays into BBC’s Question Time. In doing so, I learnt of the rise of politician David Blunkett, a...

Simulated ocular surgery: pars plana vitrectomy and scleral buckling surgery

1 August 2015 | | EYE - Oculoplastic, EYE - Orbit
See also Simulated ocular surgery and Simulated ocular surgery - strabismus surgery In this second article on ocular surgery simulation, we will discuss how vitreoretinal surgery can be simulated using high tech virtual reality modalities such as the Eyesi, as...

My Top Five: Foundation year 3 jobs for prospective ophthalmology candidates

3 February 2023 | | EYE - General
Ophthalmology specialist training (OST) is a fantastic career option, however, it is also a highly competitive specialty. There was a gradual rise in competition ratios in recent years: 3.24 (2019), 5.73 (2020), and 6.80 (2021) [1]. Many choose to pursue...

My Top Five: Foundation year 3 jobs for prospective ophthalmology candidates

3 February 2023 | | EYE - General
Ophthalmology specialist training (OST) is a fantastic career option, however, it is also a highly competitive specialty. There was a gradual rise in competition ratios in recent years: 3.24 (2019), 5.73 (2020), and 6.80 (2021) [1]. Many choose to pursue...

Broadening of treatment options for potentially blinding retinal conditions

2 August 2022 | | EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...

The use of toxin in paediatric strabismus

4 December 2025 | | EYE - Paediatrics
Strabismus is a common condition that affects up to 5% children and can be associated with abnormal visual development, double vision, loss of depth perception and impaired binocularity [1]. It can also cause cosmetic concerns, negatively impact psychosocial wellbeing and...